OKLAHOMA CITY, June 14, 2022 /PRNewswire/ — Continental Resources, Inc. (NYSE: CLR) today announced that its board of directors (the “Board”) has received a non-binding proposal letter, dated June 13, 2022, from Harold G. Hamm, on behalf of himself, the Harold G. Hamm Trust and certain…
Related Posts
Pharma Plant Machinery and Equipment Sourcing and Procurement Market Report| Top Spending Regions and Market Price Trends – Forecast and Analysis 2022-2026| SpendEdge
The “Pharma Plant Machinery and Equipment Market” report has been added to SpendEdge’s library which is trusted by more than…
Xinhua Silk Road : Le premier lot des nouveaux modèles purement électriques de SAIC Motor MG arrive en Europe
BEIJING, 7 septembre 2022 /PRNewswire/ — Le premier lot des nouveaux véhicules purement électriques de MG Motor, Mulan ou MG4…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.